Gentris

Gentris, BioFortis partner

Wednesday, September 25, 2013

Gentris, a global provider of pharmacogenomics and biorepository solutions, has partnered with BioFortis to integrate its Labmatrix and Qiagram software into Gentris’ laboratory operations. The Labmatrix and Qiagram software will provide an advanced platform for clients to view and manage samples housed in the Gentris biorepository, while simultaneously enhancing their ability to collect, harmonize and integrate multiple data sources, including clinical, molecular, patient and biospecimen data.

[Read More]

Gentris names Amelia Wall president

Friday, July 26, 2013

Gentris, a pharmacogenomics and biorepository solutions company, has named Dr. Amelia Wall Warner its new president. Warner will oversee U.S. operations, lead the development of new service offerings and develop scientific education and training programs for biobanking and pharmacogenomics.

[Read More]

Gentris collaborates on blood stability

Thursday, July 26, 2012

Gentris, a provider of pharmacogenomics and biorepository solutions, will begin a collaborative study with a major pharmaceutical company to test the long-term stability of DNA in whole blood samples that have been stored for five and 10 years.

[Read More]